We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · June 29, 2021

Prognosis and Treatment of Myositis-Associated Severe Interstitial Lung Disease

Arthritis Care & Research


Additional Info

Arthritis Care & Research
Prognosis and Treatment of Myositis-Associated Severe Interstitial Lung Disease: A Descriptive Study Using a Nation-Wide Inpatient Database in Japan
Arthritis Care Res (Hoboken) 2021 May 10;[EPub Ahead of Print], H Furuya, M Nakajima, K Ikeda, K Nakamura, H Ohbe, S Aso, R Kumazawa, T Iwamoto, A Iwata, S Furuta, H Matsui, K Fushimi, H Yasunaga, H Nakajima

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading